Statement of Changes in Beneficial Ownership (4)
May 08 2020 - 04:18PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
WIENS HAROLD J |
2. Issuer Name and Ticker or Trading Symbol
BIO-TECHNE Corp
[
TECH
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
|
(Last)
(First)
(Middle)
614 MCKINLEY PLACE NE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
5/6/2020 |
(Street)
MINNEAPOLIS, MN 55413
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 5/6/2020 | | M | | 4260.00 | A | $87.34 | 9481.00 | D | |
Common Stock | 5/6/2020 | | S(1) | | 4260.00 | D | $250.00 | 5221.00 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Option (right to buy) | $87.34 | 5/6/2020 | | M | | | 4260.00 | 10/29/2016 | 10/28/2025 | Common Stock | 4260.00 | $0.00 | 0.00 | D | |
Stock Option (right to buy) | $101.19 | | | | | | | 10/26/2017 | 10/26/2026 | Common Stock | 3985.00 | | 3985.00 | D | |
Stock Option (right to buy) | $125.05 | | | | | | | 10/25/2018 | 10/26/2027 | Common Stock | 3125.00 | | 3125.00 | D | |
Stock Option (right to buy) | $179.84 | | | | | | | 10/24/2019 | 10/25/2028 | Common Stock | 1898.00 | | 1898.00 | D | |
Stock Option (right to buy) | $201.64 | | | | | | | (2) | 10/24/2029 | Common Stock | 2011.00 | | 2011.00 | D | |
Explanation of Responses: |
(1) | The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2019. |
(2) | The option vests on the earlier of the one year anniversary of the grant date (10/24/2019) or the date of Bio-Techne 2020 annual meeting of shareholders. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
WIENS HAROLD J 614 MCKINLEY PLACE NE MINNEAPOLIS, MN 55413 | X |
|
|
|
Signatures
|
/s/ Brenda S. Furlow, attorney in fact for Harold J. Wiens pursuant to Power of Attorney previously filed | | 5/8/2020 |
**Signature of Reporting Person | Date |
Bio Techne (NASDAQ:TECH)
Historical Stock Chart
From Feb 2024 to Mar 2024
Bio Techne (NASDAQ:TECH)
Historical Stock Chart
From Mar 2023 to Mar 2024